老刘买的港股康龙化成?
1、众议院特别委员会计划限制H.R.7085,以免影响中国CDMO在美国运作。
The action comes as the House Select Committee on the Chinese Communist Party is planning to dial-back the Biosecure Act (H.R.7085) so that it doesn't prevent Chinese CDMOs from operating in the u.s.
2、H.R.7085法案发起人Mike Gallagher表示Biosecure Act法案可能会缩小范围,计划将立法聚焦在提供基因序列检测服务的企业,例如BGI。业内担心,将药明康德、药明生物等中国CDMO赶出美国将会扰乱许多药物研发项目,并且将美国企业陷入不利地位。
Gallagher is planning to focus the legislation on companies that provide genomic sequencing services,such as BGI.
Industry is concerned that driving Chinese CDMOs,such as WuXi AppTec Co.Ltd.and Wuxi Biologics Inc.,out of the U.S. would disrupt or derail a number of drug development programs and put U.S. companiesat a competitive disadvantage
3、关于H.R.7085的听证会"Growing Stakes: The Bioeconomy and National Security"将于3月7日举行。
4、参议院委员会自身共和党参议院Rand Paul强烈发对该法案,部分因为他认为国会不应该针对特定公司。
老刘买的港股康龙化成?
cro前景极不稳定
韭菜就是分析来分析去,大跌时犹犹豫豫不割肉,大涨时将信将疑不跟随,笑死。
空头回补,本周五开砸,就这么简单!!$药明康德(SH603259)$ $药明生物(02269)$
懵懵的,开板跑了,没接回去,不知道以后能不能接回去